Clinical Trial: Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Atrial Fibrillation Recurrent
Study Type: INTERVENTIONAL
Official Title: Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation
Brief Summary:
Study name: Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation.Medicine: sacubitril/valsartan (100mg) and valsartan (80mg).Rationale: The latest guidelines represent an intensified management approach to reduce or prevent morbidity associated with atrial fibrillation.They provide stronger and more specific recommendations for catheter ablation (CA) use.However, not all patients maintain sinus rhythm after CA and…
Read more